Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Clinical | Japan | 24 Mar 2017 | |
Melanoma | Clinical | Japan | 24 Mar 2017 | |
Non-Small Cell Lung Cancer | Clinical | Japan | 24 Mar 2017 | |
Non-Small Cell Lung Cancer | Clinical | Japan | 24 Mar 2017 |